Results from a new study suggest a potential way to improve the effectiveness of CAR T-cell therapy for multiple myeloma. The approach relies on a class of drugs called gamma-secretase inhibitors (GSIs), several of which have been studied to treat Alzheimer’s disease.
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/2MNjPKt
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/2MNjPKt